Trump signs order to reduce regulatory barriers to domestic pharmaceutical manufacturing -White House statement
- Trump order directs the U.S. FDA to reduce the amount of time it takes to approve domestic pharmaceutical manufacturing plants
more to come
This article was written by Eamonn Sheridan at www.forexlive.com.